Author:
Al-Obaidi Issraa,Krome Anna K.,Wagner Karl G.,Pfarr Kenneth,Kuesel Annette C.,Batchelor Hannah K.
Funder
European and Developing Countries Clinical Trials Partnership
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Parasitology
Reference130 articles.
1. World Health Organisation. Ending the neglect to attain the sustainable development goals: a road map for neglected tropical diseases 2021–2030. https://apps.who.int/iris/handle/10665/338565. Accessed on 11th Apr 2022.
2. Weng H-B, Chen H-X, Wang M-W. Innovation in neglected tropical disease drug discovery and development. Infect Dis Poverty. 2018. https://doi.org/10.1186/s40249-018-0444-1.
3. Pedrique B, Strub-Wourgaft N, Some C, Olliaro P, Trouiller P, Ford N, et al. The drug and vaccine landscape for neglected diseases (2000–11): a systematic assessment. The Lancet Global Health. 2013. https://doi.org/10.1016/S2214-109X(13)70078-0.
4. Kuesel AC. Research for new drugs for elimination of onchocerciasis in Africa. Int J Parasitol Drugs Drug Resist. 2016;6:272–86. https://doi.org/10.1016/j.ijpddr.2016.04.002.
5. Trouiller P, Olliaro P, Torreele E, Orbinski J, Laing R, Ford N. Drug development for neglected diseases: a deficient market and a public-health policy failure. Lancet. 2002;359:2188–94. https://doi.org/10.1016/s0140-6736(02)09096-7.